Ipca Takes Full Ownership Of Bayshore

Strikes Deal To Acquire Remaining 20% Holding In US Generics Firm

Ipca has struck a deal to take full ownership of US firm Bayshore Pharmaceuticals by acquiring the remaining 20% stake that it did not already own.

Pie Chart 20% 80%
Ipca has acquired the remaining 20% stake in Bayshore • Source: Alamy

More from Deals

More from Business